Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition).
Zhao B, Zhou X, Zheng P, Zhang B, Feng X, Chen J, Cai L, Chen Y, He L, Su J, Cheng S, Zeng Y, Li G, Ji B, Wu J, Feng W, Liu M, Jin Y, Liu T, Mo X, Wu J, Wu H, Zhang H, Zheng Z, Zheng Z, Sun J, Li Y; Guangdong Pharmaceutical Association, Hematology Group of Rare Disease Expert Committee of Guangdong Pharmaceutical Association.
Zhao B, et al. Among authors: he l.
Front Pharmacol. 2024 Nov 22;15:1477550. doi: 10.3389/fphar.2024.1477550. eCollection 2024.
Front Pharmacol. 2024.
PMID: 39650164
Free PMC article.
Review.